These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
193 related items for PubMed ID: 26884871
1. Clinico-pathological characteristics and prognostic factors of gastrointestinal stromal tumors among a Chinese population. Li J, Zhang H, Chen Z, Su K. Int J Clin Exp Pathol; 2015; 8(12):15969-76. PubMed ID: 26884871 [Abstract] [Full Text] [Related]
2. Role of Ki-67 as a prognostic factor in gastrointestinal stromal tumors. Belev B, Brčić I, Prejac J, Golubić ZA, Vrbanec D, Božikov J, Alerić I, Boban M, Razumović JJ. World J Gastroenterol; 2013 Jan 28; 19(4):523-7. PubMed ID: 23382631 [Abstract] [Full Text] [Related]
3. Evaluation of malignancy using Ki-67, p53, EGFR and COX-2 expressions in gastrointestinal stromal tumors. Jiang J, Jin MS, Suo J, Wang YP, He L, Cao XY. World J Gastroenterol; 2012 May 28; 18(20):2569-75. PubMed ID: 22654456 [Abstract] [Full Text] [Related]
4. Evaluation of high-risk clinicopathological indicators in gastrointestinal stromal tumors for prognosis and imatinib treatment outcome. Zhao WY, Xu J, Wang M, Zhang ZZ, Tu L, Wang CJ, Cao H, Zhang ZG. BMC Gastroenterol; 2014 Jun 07; 14():105. PubMed ID: 24906683 [Abstract] [Full Text] [Related]
5. Gastrointestinal stromal tumor: 15-years' experience in a single center. Wang M, Xu J, Zhang Y, Tu L, Qiu WQ, Wang CJ, Shen YY, Liu Q, Cao H. BMC Surg; 2014 Nov 18; 14():93. PubMed ID: 25403624 [Abstract] [Full Text] [Related]
6. Clinical and prognostic significance of Raf kinase inhibitory protein expression in gastrointestinal stromal tumors. Wang Y, Chen JJ, Wang XF, Wang Q. World J Gastroenterol; 2018 Jun 21; 24(23):2508-2517. PubMed ID: 29930472 [Abstract] [Full Text] [Related]
7. Overexpression of carbonic anhydrase II and Ki-67 proteins in prognosis of gastrointestinal stromal tumors. Liu LC, Xu WT, Wu X, Zhao P, Lv YL, Chen L. World J Gastroenterol; 2013 Apr 28; 19(16):2473-80. PubMed ID: 23674848 [Abstract] [Full Text] [Related]
8. Physician Underestimation of the Risk of Gastrointestinal Stromal Tumor Recurrence After Resection. Guérin A, Sasane M, Keir CH, Gauthier G, Macalalad AR, Wu EQ, Conley AP. JAMA Oncol; 2015 Sep 28; 1(6):797-805. PubMed ID: 26204106 [Abstract] [Full Text] [Related]
9. GIST Manifesting as a Retroperitoneal Tumor: Clinicopathologic Immunohistochemical, and Molecular Genetic Study of 112 Cases. Miettinen M, Felisiak-Golabek A, Wang Z, Inaguma S, Lasota J. Am J Surg Pathol; 2017 May 28; 41(5):577-585. PubMed ID: 28288036 [Abstract] [Full Text] [Related]
10. [Clinical characteristics and prognosis analysis of 119 cases with giant gastrointestinal stromal tumor]. Zhang P, Zeng X, Gao J, Liu W, Shuai X, Liu K, Liu X, Cai M, Cai K, Wang G, Tao K. Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Nov 25; 19(11):1290-1295. PubMed ID: 27928802 [Abstract] [Full Text] [Related]
11. The Impact of Imatinib on Survival and Treatment Trends for Small Bowel and Colorectal Gastrointestinal Stromal Tumors. Almaazmi H, Stem M, Lo BD, Taylor JP, Fang SH, Safar B, Efron JE, Atallah C. J Gastrointest Surg; 2020 Jan 25; 24(1):98-108. PubMed ID: 31388887 [Abstract] [Full Text] [Related]
12. Surgical treatment and prognostic analysis for gastrointestinal stromal tumors (GISTs) of the small intestine: before the era of imatinib mesylate. Wu TJ, Lee LY, Yeh CN, Wu PY, Chao TC, Hwang TL, Jan YY, Chen MF. BMC Gastroenterol; 2006 Oct 24; 6():29. PubMed ID: 17062131 [Abstract] [Full Text] [Related]
13. SLITRK3 expression correlation to gastrointestinal stromal tumor risk rating and prognosis. Wang CJ, Zhang ZZ, Xu J, Wang M, Zhao WY, Tu L, Zhuang C, Liu Q, Shen YY, Cao H, Zhang ZG. World J Gastroenterol; 2015 Jul 21; 21(27):8398-407. PubMed ID: 26217092 [Abstract] [Full Text] [Related]
14. Expression of cell cycle regulators and frequency of TP53 mutations in high risk gastrointestinal stromal tumors prior to adjuvant imatinib treatment. Ihle MA, Huss S, Jeske W, Hartmann W, Merkelbach-Bruse S, Schildhaus HU, Büttner R, Sihto H, Sundby Hall K, Eriksson M, Reichardt P, Joensuu H, Wardelmann E. PLoS One; 2018 Jul 21; 13(2):e0193048. PubMed ID: 29451912 [Abstract] [Full Text] [Related]
15. [Prognosis analysis of 247 cases of gastrointestinal stromal tumor]. Ning L, Zhang DF, Zhou YB, Jiao XL, Cao SG. Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Mar 21; 16(3):247-50. PubMed ID: 23536345 [Abstract] [Full Text] [Related]
16. Prognostic value of Ki67 index in gastrointestinal stromal tumors. Zhao WY, Xu J, Wang M, Zhang ZZ, Tu L, Wang CJ, Lin TL, Shen YY, Liu Q, Cao H. Int J Clin Exp Pathol; 2014 Mar 21; 7(5):2298-304. PubMed ID: 24966939 [Abstract] [Full Text] [Related]
17. Surgery for Duodenal Gastrointestinal Stromal Tumors: A Single-Center Experience. Chen P, Song T, Wang X, Zhou H, Zhang T, Wu Q, Kong D, Cui Y, Li H, Li Q. Dig Dis Sci; 2017 Nov 21; 62(11):3167-3176. PubMed ID: 28914399 [Abstract] [Full Text] [Related]
19. Clinicopathological and Prognostic Features of Surgical Management in Duodenal Gastrointestinal Stromal Tumors. Shi HP, Huang ML, Wang ZQ, Zheng YN, Zhu ZL, Sah BK, Liu WT, Yan M, Zhu ZG, Li C. Dig Surg; 2018 Jul 21; 35(6):498-507. PubMed ID: 29232679 [Abstract] [Full Text] [Related]
20. Gastrointestinal stromal tumors (GIST): a single center experience. Kostka R, Gürlich R, Koldová L. Acta Chir Belg; 2012 Jan 21; 112(1):33-9. PubMed ID: 22442907 [Abstract] [Full Text] [Related] Page: [Next] [New Search]